Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $GRCE
Grace Therapeutics Inc.
Subscribe to $GRCE
$GRCE
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year:
Exchange: NASDAQ
Recent Analyst Ratings for Grace Therapeutics Inc.
Date
Price Target
Rating
Analyst
5/2/2025
$12.00
Buy
TD Cowen
See more ratings
